Clinical Trial Update: The Nonirritating Concentrations of Midazolam, Ketamine, and Ondansetron [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing nonirritating concentrations of midazolam, ketamine, and ondansetron in patients with allergy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergy

Drugs mentioned

• Ketalar (ketamine)
• Versed (Midazolam)
• Zofran (Ondansetron)

Snippet

Sponsor: Mayo Clinic | Conditions: Allergy | Phase 4 | Status: COMPLETED